Phenelzine sulfate: Clinical Trials

4 trials of Phenelzine sulfate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Phase 22Completed 1, Terminated 1

Follow Phenelzine sulfate: new trials by email Literature Review of Phenelzine sulfate trials Research Report on Phenelzine sulfate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study in Healthy People to Test How Combining BI 1467335 and Tyramine Affects Blood Pressure
BI 1467335, Placebo, Phenelzine sulfate - Healthy
Phase 1TerminatedBoehringer Ingelheim532019-07-312021-06-04
An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast Cancer
Nanoparticle albumin-bound paclitaxel, Phenelzine Sulfate - Metastatic Breast Cancer
Phase 1CompletedEpiAxis Therapeutics82017-08-172019-11-13
Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer
phenelzine sulfate, laboratory biomarker analysis, questionnaire administration - Adenocarcinoma of the Prostate, Recurrent Prostate Cancer
Phase 2CompletedUniversity of Southern California262014-09-082026-06-25
Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel
Biopsy of Prostate, Docetaxel, Laboratory Biomarker Analysis - Hormone-Resistant Prostate Cancer, Metastatic Prostatic Adenocarcinoma
Phase 2TerminatedOHSU Knight Cancer Institute112010-07-122019-10-02

Conditions studied

Prostatic Neoplasms (2)  ·  Breast Neoplasms (1)

Sponsors

Boehringer Ingelheim (1)  ·  EpiAxis Therapeutics (1)  ·  OHSU Knight Cancer Institute (1)  ·  University of Southern California (1)

Countries

United States (2)  ·  Australia (1)  ·  Netherlands (1)

Top investigators

Desmond Yip, MBBS (1)  ·  Jean C. Shih, PhD (1)  ·  Laeeq Malik, MBBS (1)  ·  Mitchell Gross, MD (1)  ·  Tomasz Beer (1)

Results publications

PMID 35719960, PMID 40932155

NIH funding

2018 (1), P30CA014089 (1), P30CA069533 (1)